Doctors are preparing for greater public scrutiny of the gifts and payments medical device makers and drugmakers give them as companies record almost all transactions with physicians in accordance with the Sunshine Act beginning this month. Greater disclosures are pushing doctors to reconsider their relationships with manufacturers. "The idea is that transparency will encourage doctors to evaluate whether these are appropriate relationships with companies or not," the Pew Charitable Trusts' Dr. Daniel Carlat said.
Physicians gear up for greater scrutiny under Sunshine Act
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||